K
K.H. Katsanos
Researcher at University of Ioannina
Publications - 68
Citations - 1982
K.H. Katsanos is an academic researcher from University of Ioannina. The author has contributed to research in topics: Inflammatory bowel disease & Ulcerative colitis. The author has an hindex of 15, co-authored 67 publications receiving 1775 citations.
Papers
More filters
Journal ArticleDOI
European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.
Jean-François Rahier,Fernando Magro,Candida Abreu,Alessandro Armuzzi,Shomron Ben-Horin,Yehuda Chowers,Mario Cottone,L. de Ridder,Glen A. Doherty,Robert Ehehalt,Maria Esteve,K.H. Katsanos,Charlie W. Lees,Eithne MacMahon,Tom G. Moreels,Walter Reinisch,Herbert Tilg,Lydjie Tremblay,Gigi Veereman-Wauters,N. Viget,Yazdan Yazdanpanah,Rami Eliakim,Jean-Frederic Colombel +22 more
TL;DR: The treatment of inflammatory bowel disease has been revolutionised over the past decade by the increasing use of immunomodulators, mainly azathioprine/6-mercaptopurine and methotrexate, together with the advent of biological therapy.
Journal ArticleDOI
Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort.
Z. Vegh,Z. Vegh,Johan Burisch,Niels C Pedersen,I. Kaimakliotis,Dana Duricova,Martin Bortlik,Søren Avnstrøm,K. Kofod Vinding,J. Olsen,K R Nielsen,K.H. Katsanos,E.V. Tsianos,Laszlo Lakatos,Doron Schwartz,Shmuel Odes,Guido Lupinacci,A. De Padova,Laimas Virginijus Jonaitis,Limas Kupčinskas,Svetlana Turcan,O Tighineanu,I Mihu,L. Barros,Fernando Magro,Daniela Lazăr,Adrian Goldis,Alberto Fernandez,Vicent Hernandez,O Niewiadomski,Sally Bell,Ebbe Langholz,Pia Munkholm,Peter L. Lakatos,EpiCom-group +34 more
TL;DR: Incidence rates, disease phenotype and initial treatment characteristics in the 2011 ECCO-EpiCom cohort were not significantly different from that reported in the 2010 cohort.
Journal ArticleDOI
The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and Therapy.
Charlotte Hedin,Stephan R. Vavricka,Andrew J. Stagg,Alain M. Schoepfer,Tim Raine,Lluís Puig,U Pleyer,Alexander A. Navarini,A E van der Meulen-de Jong,Jochen Maul,K.H. Katsanos,A Kagramanova,Thomas Greuter,Thomas Greuter,Yago Gonzalez-Lama,F. A. van Gaalen,Pierre Ellul,Johan Burisch,Dominik Bettenworth,M D Becker,Giorgos Bamias,Florian Rieder +21 more
TL;DR: This article reports on the sixth scientific workshop of the European Crohn's and Colitis Organisation [ECCO] on the pathogenesis of extraintestinal manifestations [EIMs] in inflammatory bowel disease [IBD].
Journal ArticleDOI
Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe — An ECCO-EpiCom study
Johan Burisch,Niels C Pedersen,Silvija Čuković-Čavka,Nikša Turk,I. Kaimakliotis,Dana Duricova,Martin Bortlik,Olga Shonová,Ida Vind,Søren Avnstrøm,Niels Thorsgaard,Susanne Krabbe,Vibeke Andersen,Jens Frederik Dahlerup,Jens Kjeldsen,Riina Salupere,J. Olsen,K R Nielsen,Pia Manninen,Pekka Collin,K.H. Katsanos,E.V. Tsianos,K. Ladefoged,Laszlo Lakatos,G. Ragnarsson,Einar Bjornsson,Y. Bailey,Colm O'Morain,Doron Schwartz,Shmuel Odes,M. Giannotta,G. Girardin,Gediminas Kiudelis,Limas Kupčinskas,Svetlana Turcan,L. Barros,Fernando Magro,Daniela Lazăr,Adrian Goldis,Inna Nikulina,Elena Belousova,David Martínez-Ares,Vicent Hernandez,Sven Almer,Yaroslava Zhulina,Jonas Halfvarson,Naila Arebi,H. H. Tsai,Shaji Sebastian,Peter L. Lakatos,Ebbe Langholz,Pia Munkholm +51 more
TL;DR: In this European population-based inception cohort of unselected IBD patients, Eastern and Western European patients differing in environmental factors prior to diagnosis exhibited higher occurrences of suspected risk factors for IBD included in the Western lifestyle.
Journal ArticleDOI
The prevalence of genetic and serologic markers in an unselected European population‐based cohort of IBD patients
Lene Riis,Ida Vind,Severine Vermeire,Frank Wolters,K.H. Katsanos,P. Politi,Joao Freitas,Ioannis A. Mouzas,Colm O'Morain,Victor Ruiz‐Ochoa,Selwyn Odes,Vibeke Binder,Pia Munkholm,Bjørn Moum,Reinhold W. Stockbrügger,Ebbe Langholz +15 more
TL;DR: The prevalence of mutations in CARD15 varied across Europe, and was not correlated to the incidence of CD, and there was no association between mutations in TLR4 and IBD.